Phase 3 Safety and Immunogenicity Study of aQIV in Elderly Adults

Conditions

• Influenza, Human

Interventions

• BIOLOGICAL: MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV)
• BIOLOGICAL: Licensed MF59-adjuvanted Trivalent Subunit Inactivated Egg-derived Influenza Vaccine (aTIV-1)
• BIOLOGICAL: MF59-adjuvanted Trivalent Subunit Inactivated Egg-derived Influenza Vaccine Containing the Alternate B Strain (aTIV-2)

Sponsor

Seqirus